Fighting TB – South Africa’s ‘insidious epidemic’

TL;DR

Despite having a TB vaccine since 1921, South Africa faces a critical TB epidemic, driving the need for new vaccines.

Transcript

we have an urgent tuberculosis epidemic with the incidence of TB in South Africa today particularly in Cape Town being equivalent to what it was in London in the eighteen hundreds we have a vaccine against tuberculosis we have BCG which has been around since 1921 yet it's by no means a perfect vaccine our search is for a new and effective vaccine t... Read More

Key Insights

• 🌚 South Africa faces a critical tuberculosis epidemic, requiring new and effective vaccines for prevention.
• 🇨🇫 The South African Tuberculosis Vaccine Initiative focuses on the discovery and development of improved TB vaccines.
• 👨‍🔬 Collaborative partnerships between research groups, like UCT and University of Oxford, are crucial for advancing TB vaccine research.
• 👶 Clinical trials for new TB vaccines are vital for testing efficacy and safety in real-world settings.
• 🇿🇦 Infrastructure and disease expertise in countries like South Africa play a significant role in TB vaccine development.
• 🥳 Equal partnerships in research collaborations ensure mutual benefits and fruitful outcomes for all parties involved.
• ✋ The urgent need for safer and more efficient TB vaccines stems from the high TB burden and disease prevalence in communities like Worcester.

Questions & Answers

Q: Why is South Africa facing a tuberculosis epidemic despite having a vaccine?

South Africa's TB epidemic persists due to factors like high disease burden, insufficient vaccine efficacy, and the need for newer, more effective vaccines.

Q: What is the purpose of the South African Tuberculosis Vaccine Initiative?

The initiative aims to engage in the discovery and development of improved tuberculosis vaccines, leveraging collaborative networks and infrastructure to address the pressing TB crisis.

Q: How does collaboration between research groups help in TB vaccine development?

Collaborative partnerships, like the one between UCT and the University of Oxford, combine expertise in vaccine development, clinical trials, disease knowledge, and infrastructure to advance TB vaccine research effectively.

Q: Why is it crucial to develop new TB vaccines that are safe and effective globally?

Developing new TB vaccines is essential to combat the evolving nature of the disease, address vaccine limitations, and protect vulnerable populations worldwide from the TB epidemic.

Summary & Key Takeaways

• South Africa is experiencing a severe tuberculosis epidemic, with a high TB incidence in Cape Town akin to that of 1800s London.

• The search is on for a safer, more effective TB vaccine that caters to both infants and adults globally.

• Collaborative efforts, like the South African Tuberculosis Vaccine Initiative, are essential for vaccine discovery and testing.